DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Intetumumab
Intetumumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
International Nonproprietary Names for Pharmaceutical Substances (INN)
Tanibirumab (CUI C3490677) Add to Cart
(12) United States Patent (10) Patent No.: US 9,161,992 B2 Jefferies Et Al
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
Prescrire's Response
V-Integrin Mab, Alone and with Dacarbazine in Stage IV Melanoma
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
INN Working Document 05.179 Update December 2010
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
(INN) for Biological and Biotechnological Substances
Ep 2739649 B1
A61K9/51 (2006.01) — with International Search Report (Art
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
Top View
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Mai Muita in Acut Ca Uti on Muunni
Integrins As Therapeutic Targets: Successes and Cancers
(12) United States Patent (10) Patent No.: US 9.295,731 B2 Nguyen (45) Date of Patent: Mar
Biotechnology Presented by America’S Biopharmaceutical Research Companies
(12) Patent Application Publication (10) Pub. No.: US 2015/0322155A1 Zhao (43) Pub
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Pharmacological and Clinical Importance of Integrin Antagonists
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Anti-Alphavbeta3 Monoclonal Antibody EMD 525797 (CUI C2830088) Add to Cart
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
Ramesh Rengan, MD Ph.D. Radiation Therapy Contraindications And
Dihydropyrrolidino-Pyrimidines As Kinase Inhibitors Dihydropyrrolidinpyrimidine Als Kinaseinhibitoren Dihydropyrrolidinopyrimidines Comme Inhibiteurs De Kinase
Ep 3088005 A1
WO 2015/127407 Al 27 August 2015 (27.08.2015) P O P C T
Oncology Drugs in the Pipeline
Timepoint 1 Geting Assembly Complexes (Attacs) for Selectively Activating De¬ Sired Immune Cells in the Tumor Microenvironment
(12) United States Patent (10) Patent No.: US 9,364,567 B2 Vitalis Et Al
High Αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats YINGJEN JEFFREY WU 1, MICHAEL A
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al
Human BMPR1B Amino Acid Sequence